CME Group Inc. CME SPX
Company Overview
CME Group Inc., together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, and foreign exchange; and agricultural, energy, and metals commodities, as well as fixed income and foreign currency trading services. The company provides clearing house services, including clearing, settling, and guaranteeing futures and options contracts, and cleared swaps products traded through its exchanges. In addition, the company offers a range of market data services, including real-time and historical data services. It serves professional traders, financial institutions, institutional and individual investors, corporations, manufacturers, producers, governments, and central banks. The company was formerly known as Chicago Mercantile Exchange Holdings Inc. and changed its name to CME Group Inc. in July 2007. The company was founded in 1898 and is headquartered in Chicago, Illinois.
Why Investors Should Care
Generates a return on equity of 15.9%, reflecting efficient use of shareholder capital.
Net profit has compounded at 10.7% per year over the last five years.
Maintains a net profit margin of 63.3%.
Carries low leverage with a debt-to-equity ratio of 0.14.
Offers a dividend yield of 2.12%.
Generates positive free cash flow, funding growth and shareholder returns internally.
Recent Developments
- Dec 2025 Revenue of $6.52B (+6.4% YoY); net profit $4.07B.
- Trailing 12 Months Year-on-year growth — revenue +14.4%, earnings +21.3%.
- 5-Year Trend Long-term compounding — revenue CAGR 7.6%, profit CAGR 10.7%.
Growth & Price Performance
Compounded Sales Growth
| 5 Years: | 7.56% |
| 1 Year: | 14.40% |
Compounded Profit Growth
| 5 Years: | 10.65% |
| 1 Year: | 21.30% |
Stock Price Performance
| 1 Year: | -8.06% |
| 6 Months: | -4.77% |
| 3 Months: | -17.03% |
| 1 Month: | -9.03% |
Highlights auto-generated from reported financials and price data; not investment advice. Verify with official filings before acting.
- Price vs 50-DMABelow
- Price vs 200-DMABelow
- RSI (14)49.21 · Neutral
P/E of 21.06 is above the sector median of 13.52 — pricier than peers.
Auto-generated from price history and fundamentals; not investment advice.
Price Chart
Technical Trend
Computed from daily close history using EMA cross, slope, and RSI signals.
Note: intraday data is not stored locally. “Hourly” uses the most recent 10 daily candles as a short-term proxy.
Fundamental Growth Charts
No fundamental data available for this stock.
Interactive charts for Revenue, Net Income, EBITDA, Free Cash Flow, EPS, ROE, ROCE, Gross/Net/Operating Margin and more — switch metric and period using the dropdowns above. CAGR is computed across the displayed window (quarterly CAGR is annualised). Visual growth charts make it easy to spot multi-year compounding trends at a glance — far faster than reading raw numbers in a table.
PROS
- Excellent profit margin of 63.3%.
- Profit CAGR of 10.7% over 5 years.
- Generates positive free cash flow.
CONS
- In a downtrend (50-DMA below 200-DMA).
* The pros and cons are auto-generated from financial metrics.
Valuation
Growth (CAGR)
Profitability & Returns
Balance Sheet & Liquidity
Ownership
Financial Snapshot
Peer comparison
Peer companies in the same sector (Financial Services).
| # | Name | CMP $ | P/E | Mkt Cap | Div Yld % | ROCE % | ROE % | Rev CAGR 5Y % | Profit CAGR 5Y % |
|---|---|---|---|---|---|---|---|---|---|
| 1 | CME CME Group Inc. SPX | 245.18 | 21.06 | $88.59B | 2.12% | 11.09% | 15.92% | 7.56% | 10.65% |
| 2 | JPM JPMorgan Chase & Co. SPX | 346.91 | 16.61 | $929.55B | 1.87% | - | 16.47% | 5.35% | 7.56% |
| 3 | BRK-B Berkshire Hathaway Inc. SPX | 488.35 | 14.54 | $682.86B | 0.00% | - | 10.50% | 4.18% | 9.44% |
| 4 | V Visa Inc. SPX | 355.14 | 30.99 | $589.43B | 0.75% | 37.15% | 60.35% | 14.33% | 13.04% |
| 5 | MA Mastercard Incorporated SPX | 535.21 | 30.99 | $469.40B | 0.65% | 60.19% | - | 12.29% | 19.21% |
| 6 | BAC Bank of America Corporation SPX | 61.59 | 15.28 | $432.24B | 1.88% | - | 10.64% | 6.00% | 3.49% |
| 7 | MS Morgan Stanley SPX | 228.55 | 20.70 | $360.49B | 1.76% | - | 16.39% | 3.76% | 9.66% |
| 8 | GS The Goldman Sachs Group, Inc. SPX | 1,152.07 | 17.79 | $339.87B | 1.58% | - | 16.95% | - | 2.21% |
| 9 | WFC Wells Fargo & Company SPX | 87.51 | 13.53 | $267.80B | 2.11% | - | 12.03% | 4.02% | 15.98% |
Financial Statements Quarterly Results · Profit & Loss · Balance Sheet · Cash Flows · Ratios
Quarterly Results
Figures in USD.
| Metric | Mar 2015 | Jun 2015 | Sep 2015 | Dec 2015 | Mar 2016 | Jun 2016 | Sep 2016 | Dec 2016 | Mar 2017 | Jun 2017 | Sep 2017 | Dec 2017 | Mar 2018 | Jun 2018 | Sep 2018 | Dec 2018 | Mar 2019 | Jun 2019 | Sep 2019 | Dec 2019 | Mar 2020 | Jun 2020 | Sep 2020 | Dec 2020 | Mar 2021 | Jun 2021 | Sep 2021 | Mar 2022 | Jun 2022 | Sep 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 842.70M | 820.00M | 850.30M | 813.80M | 934.20M | 906.40M | 841.70M | 912.90M | 929.30M | 924.60M | 890.80M | 900.00M | 1.11B | 1.06B | 904.20M | 1.24B | 1.18B | 1.27B | 1.28B | 1.14B | 1.52B | 1.18B | 1.08B | 1.10B | 1.25B | 1.18B | 1.11B | 1.35B | 1.24B | 1.23B | 1.44B | 1.36B | 1.34B | 1.49B | 1.53B | 1.58B | 1.64B | 1.69B | 1.54B | 1.88B |
| Operating Income | 507.30M | 495.10M | 516.40M | 469.90M | 573.90M | 563.30M | 525.30M | 540.20M | 600.90M | 605.20M | 567.60M | 536.90M | 740.90M | 666.90M | 549.90M | 649.90M | 631.00M | 698.60M | 685.20M | 573.00M | 959.90M | 637.50M | 525.00M | 515.00M | 725.10M | 674.70M | 613.70M | 859.10M | 749.70M | 738.80M | 913.70M | 838.60M | 820.20M | 959.60M | 1.00B | 1.02B | 1.11B | 1.13B | 972.60M | 1.31B |
| Net Income | 330.40M | 265.00M | 359.90M | 291.70M | 367.80M | 320.10M | 472.80M | 373.40M | 399.80M | 415.80M | 308.60M | 2.94B | 598.80M | 566.10M | 411.80M | 385.50M | 496.90M | 513.80M | 636.30M | 469.50M | 766.20M | 503.30M | 411.70M | 424.00M | 574.40M | 510.30M | 926.50M | 711.00M | 662.50M | 679.60M | - | - | - | - | - | - | - | - | - | - |
| Diluted EPS | 0.98 | 0.78 | 1.06 | 0.86 | 1.09 | 0.95 | 1.39 | 1.10 | 1.18 | 1.22 | 0.91 | 8.63 | 1.76 | 1.66 | 1.21 | 1.09 | 1.39 | 1.43 | 1.78 | 1.31 | 2.14 | 1.40 | 1.15 | 1.18 | 1.60 | 1.42 | 2.58 | 1.95 | 1.82 | 1.87 | 2.43 | 2.14 | 2.06 | 2.35 | 2.42 | 2.50 | 2.62 | 2.81 | 2.49 | 3.18 |
Profit & Loss (Annual)
Figures in USD.
| Metric | Dec 2007 | Dec 2008 | Dec 2009 | Dec 2010 | Dec 2011 | Dec 2012 | Dec 2013 | Dec 2014 | Dec 2015 | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 1.76B | 2.56B | 2.61B | 3.00B | 3.28B | 2.91B | 2.94B | 3.11B | 3.33B | 3.60B | 3.64B | 4.31B | 4.87B | 4.88B | 4.69B | 5.02B | 5.58B | 6.13B | 6.52B |
| Operating Income | 1.05B | 1.58B | 1.59B | 1.83B | 2.02B | 1.69B | 1.64B | 1.77B | 1.99B | 2.20B | 2.31B | 2.61B | 2.59B | 2.64B | 2.65B | 3.02B | 3.44B | 3.93B | 4.23B |
| Net Income | 658.50M | 715.50M | 825.80M | 951.40M | 1.81B | 896.30M | 976.80M | 1.13B | 1.25B | 1.53B | 4.06B | 1.96B | 2.12B | 2.11B | 2.64B | 2.69B | 3.23B | 3.53B | 4.07B |
| Diluted EPS | 14.93 | 12.13 | 12.41 | 2.86 | 5.43 | 2.70 | 2.92 | 3.35 | 3.69 | 4.53 | 11.94 | 5.71 | 5.91 | 5.87 | 7.29 | 7.40 | 8.86 | 9.67 | 11.16 |
Balance Sheet (Annual)
Figures in USD.
| Metric | Dec 2006 | Dec 2007 | Dec 2008 | Dec 2009 | Dec 2010 | Dec 2011 | Dec 2012 | Dec 2013 | Dec 2014 | Dec 2015 | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Assets | - | - | 48.16B | 35.65B | 35.05B | 40.76B | 38.86B | 54.28B | 72.24B | 67.36B | 69.37B | 75.79B | 77.48B | 75.22B | 124.66B | 196.78B | 174.18B | 129.71B | 137.45B | 198.42B |
| Total Equity | 1.52B | 12.31B | 18.69B | 19.30B | 20.06B | 21.55B | 21.42B | 21.15B | 20.92B | 20.55B | 20.34B | 22.41B | 25.92B | 26.13B | 26.32B | 27.40B | 26.88B | 26.74B | 26.49B | 28.73B |
| Cash & Equivalents | 969.50M | 845.30M | 297.90M | 260.60M | 855.20M | 1.04B | 1.60B | 2.47B | 1.37B | 1.69B | 1.87B | 1.90B | 1.37B | 1.55B | 1.63B | 2.83B | 2.72B | 2.91B | 2.89B | 4.42B |
| Total Liabilities | - | - | 29.47B | 16.35B | 14.92B | 19.14B | 17.36B | 33.12B | 51.32B | 46.81B | 49.03B | 53.38B | 51.51B | 49.06B | 98.31B | 169.38B | 147.30B | 102.97B | 110.96B | 169.70B |
| Current Liabilities | - | - | 18.64B | 6.52B | 4.78B | 9.62B | 7.62B | 23.31B | 41.53B | 36.82B | 38.95B | 45.67B | 41.27B | 38.52B | 88.20B | 160.40B | 137.69B | 93.42B | 102.31B | 160.30B |
Cash Flows (Annual)
Figures in USD.
| Metric | Dec 2007 | Dec 2008 | Dec 2009 | Dec 2010 | Dec 2011 | Dec 2012 | Dec 2013 | Dec 2014 | Dec 2015 | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | 814.40M | 1.20B | 1.08B | 1.36B | 1.35B | 1.22B | 1.28B | 1.29B | 1.53B | 1.73B | 1.75B | 2.44B | 2.67B | 2.72B | 2.40B | 3.06B | 3.45B | 3.69B | 4.28B |
| Investing Cash Flow | -78.70M | -3.75B | 544.80M | -111.60M | -153.60M | -208.90M | 190.50M | -199.10M | 17.90M | 53.70M | 179.90M | -1.89B | -152.60M | -175.50M | 58.40M | -489.80M | 20.90M | -82.60M | 1.50B |
| Financing Cash Flow | -859.90M | 2.00B | -1.67B | -653.40M | -1.01B | -448.40M | -606.00M | -2.20B | -1.22B | -1.62B | -1.99B | -1.08B | -2.34B | 47.25B | 69.91B | -25.38B | -48.34B | 5.08B | 56.51B |
| Capital Expenditure | -163.70M | -200.10M | -157.90M | -160.00M | -172.20M | -141.80M | -125.60M | -140.70M | -114.20M | -91.80M | -81.90M | -116.70M | -245.60M | -197.50M | -127.20M | -89.70M | -76.40M | -94.00M | -83.50M |
| Free Cash Flow | 650.70M | 997.10M | 925.20M | 1.20B | 1.17B | 1.08B | 1.15B | 1.15B | 1.42B | 1.64B | 1.67B | 2.32B | 2.43B | 2.52B | 2.28B | 2.97B | 3.38B | 3.60B | 4.19B |
| Share Buybacks | 949.30M | 224.00M | 27.00M | 575.30M | 220.40M | 0 | 0 | - | - | - | - | - | - | - | - | - | - | - | - |
| Dividends Paid | 151.60M | 615.20M | 305.60M | 305.30M | 372.80M | 1.22B | 599.10M | 1.50B | 1.34B | 1.79B | 1.99B | 2.15B | 1.70B | 2.11B | 2.19B | 2.63B | 3.24B | 3.58B | 3.93B |
Ratios (Annual)
Figures in %.
| Metric | Dec 2007 | Dec 2008 | Dec 2009 | Dec 2010 | Dec 2011 | Dec 2012 | Dec 2013 | Dec 2014 | Dec 2015 | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Operating Margin % | 59.9% | 61.8% | 60.8% | 61.0% | 61.6% | 58.1% | 55.8% | 56.8% | 59.8% | 61.2% | 63.4% | 60.5% | 53.2% | 54.0% | 56.4% | 60.1% | 61.6% | 64.1% | 64.9% |
| Net Margin % | 37.5% | 27.9% | 31.6% | 31.7% | 55.2% | 30.8% | 33.3% | 36.2% | 37.5% | 42.7% | 111.5% | 45.5% | 43.5% | 43.1% | 56.2% | 53.6% | 57.8% | 57.5% | 62.5% |
| ROE % | 5.4% | 3.8% | 4.3% | 4.7% | 8.4% | 4.2% | 4.6% | 5.4% | 6.1% | 7.5% | 18.1% | 7.6% | 8.1% | 8.0% | 9.6% | 10.0% | 12.1% | 13.3% | 14.2% |
| ROCE % | - | 5.4% | 5.5% | 6.1% | 6.5% | 5.4% | 5.3% | 5.8% | 6.5% | 7.2% | 7.7% | 7.2% | 7.1% | 7.2% | 7.3% | 8.3% | 9.5% | 11.2% | 11.1% |
Shareholding Pattern
Top Institutional Holders
| # | Holder | % Held | Shares | Value |
|---|---|---|---|---|
| 1 | Blackrock Inc. | 8.68% | 31.45M | $7.66B |
| 2 | Vanguard Capital Management LLC | 6.45% | 23.37M | $5.69B |
| 3 | State Street Corporation | 4.43% | 16.06M | $3.91B |
| 4 | JPMORGAN CHASE & CO | 3.37% | 12.21M | $2.97B |
| 5 | Morgan Stanley | 2.60% | 9.41M | $2.29B |
| 6 | Geode Capital Management, LLC | 2.52% | 9.15M | $2.23B |
| 7 | Vanguard Portfolio Management LLC | 2.49% | 9.03M | $2.20B |
| 8 | Capital World Investors | 1.91% | 6.94M | $1.69B |
| 9 | Bank Of New York Mellon Corporation | 1.33% | 4.83M | $1.18B |
| 10 | Price (T.Rowe) Associates Inc | 1.33% | 4.81M | $1.17B |
Analyst View
Analyst aggregate. Targets and ratings update periodically; not investment advice.
Latest News
Recent headlines for CME
Equity index futures finished mixed following sharp cooling in CPI. - CME Group
<a href="https://news.google.com/rss/articles/CBMisgFBVV95cUxQRW9aaVB4YWt0Zm44YmxVOUtXU0FuQ2x6ckU4eXJzRXBLWXk5MnFNdmhxOTZsOWNuV3FSV3FaX3FvMk9pSUxCalBXTldYSHNOcnBGRGVmZndNMDY2SDVOeWttaVI0VmdHS3VtbXBreUI2TFRoTmRnTzdEVzlZZF80Nm9jZ3JLaFlZZnp1TW…
CME Group stock may shift 3.8% on July 22 earnings release - Investing.com
<a href="https://news.google.com/rss/articles/CBMiugFBVV95cUxQdVNCOVcwOFM1em80WHdOS0x1UDRBQTUwdnZSUU5LdHZvb29yRWNIbDJRcWpBNEU3NzFPN09xLVM0bEZ6Y2NSaV9VS25lMDlDbG9Jd0g0cFFJRWtnM25CbEpXbUdiTGNVYjRLbGNjUENpbk9US2tMdEVoSTRLWEllWUJna1pXdkJaN1lFd0…
CME Group (CME) Stock Price Pullback Sparks Fresh Questions On Valuation - Yahoo Finance
<a href="https://news.google.com/rss/articles/CBMilAFBVV95cUxORXJIVWhqRHlSREUyRHNJTVVSR0Y3dEZHSU5iLWx6T3ZlamZTQnVBdURCTENoZFFrWUlTRU03RXc3WmQtT09uYVpYTFJPVFBJUnRxZTF2VTV5VTc1ODV1VVYtRDc2dWVydHRXd2QzY1Bka191R0drSWRMVnJVeXBwRFBUSFN3MDRHQ0JEST…
Chicago SRW Wheat - CME Group
<a href="https://news.google.com/rss/articles/CBMiaEFVX3lxTE1RV2pNcElyMDA2cWoteUpYX2ZsQko4N1R0TTljZmJGbV9YVnZXdW1TYlNZR3NBOUM2SmdSOXVsREJ3UXRDUHY1TzhQLWlySy1jSUZ0LWpCLTFMSUZFR0wyRjFTcXhQWUpa?oc=5" target="_blank">Chicago SRW Wheat</a> …
CME Group (CME) Expands Its Product Suite, Is The Stock Cheap? - simplywall.st
<a href="https://news.google.com/rss/articles/CBMi1gFBVV95cUxQM21mMDhjUi1iVFFkbmdaTjd6eERmdjZCN3BtcGhxT242MG51TUxiRzBhTG9OSWc0T1BYN0Z3U3JsNU9SVnJ3Ykp2WTdQNFJfeXJmV2JBTmpfQWNpNEFvWTQ2RmE0dENVMUlQcXRoeUZBUjB0WVhScXMwMkQ0N1Q4b3ozMHVsaEJWSVZacj…
The CME’s lawsuit against the CFTC is worth reading - Financial Times
<a href="https://news.google.com/rss/articles/CBMicEFVX3lxTE5DZXc0WG9iZl85Qno0VXMzV1lMR09UMHlLNGFkdnJBa0d1V2VJWVNmMXlwSWc0M0U2SmJKSVBkLWc5UllURnhTdHBnZFA2OEpObTJCLTVXWlRmNHNBdWp2V08tWk5UMTNxTzhpV1puT3g?oc=5" target="_blank">The CME’s lawsui…
CME — Frequently Asked Questions
What is the current share price of CME Group Inc. (CME)?
As of 2026-07-15 16:51 PDT, CME Group Inc. (CME) trades at $245.18 on NasdaqGS. Its 52-week range is $218.58 to $317.19.
What is the market capitalisation of CME?
CME Group Inc. (CME) has a market capitalisation of $88.59B on NasdaqGS.
What is the P/E ratio of CME?
CME trades at a trailing price-to-earnings (P/E) ratio of 21.06. The industry average P/E is 13.52. Its price-to-book (P/B) ratio is 3.31.
Does CME pay a dividend?
CME Group Inc. (CME) currently offers a dividend yield of 2.12%.
What is the return on equity (ROE) of CME?
CME has a return on equity (ROE) of 15.92%. Its return on capital employed (ROCE) is 11.09%.
Is CME a good stock to buy?
This page provides a data-driven analysis of CME Group Inc. (CME), including valuation ratios, profitability, growth trends, auto-generated pros and cons, peer comparison and AI exposure. Review these fundamentals alongside your own research and risk tolerance. This is informational content, not investment advice.